Authors: Kadereit, S Kozik, MM Junge, GR Miller, RE Slivka, LF Bos, LS Daum-Woods, K Sramkoski, RM Jacobberger, JW Laughlin, MJ

Citation: S. Kadereit et al., Cyclosporin A effects during primary and secondary activation of human umbilical cord blood T lymphocytes, EXP HEMATOL, 29(7), 2001, pp. 903-909

Authors: Laughlin, MJ

Citation: Mj. Laughlin, Umbilical cord blood for allogeneic transplantation in children and adults, BONE MAR TR, 27(1), 2001, pp. 1-6

Authors: Laughlin, MJ Barker, J Bambach, B Koc, ON Rizzieri, DA Wagner, JE Gerson, SL Lazarus, HM Cairo, M Stevens, CE Rubinstein, P Kurtzberg, J

Citation: Mj. Laughlin et al., Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors., N ENG J MED, 344(24), 2001, pp. 1815-1822

Authors: Tallman, MS Rowlings, PA Milone, G Zhang, MJ Perez, WS Weisdorf, D Keating, A Gale, RP Geller, RB Laughlin, MJ Lazarus, HM Luger, SM McCarthy, PL Rowe, JM Saez, RA Vowels, MR Horowitz, MM

Citation: Ms. Tallman et al., Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission, BLOOD, 96(4), 2000, pp. 1254-1258

Authors: Laughlin, MJ

Citation: Mj. Laughlin, What is an accurate risk/benefit ratio for umbilical cord cell transplantation in children and adults?, CUR CLIN ON, 2000, pp. 41-52

Authors: Kadereit, S Mohammad, SF Miller, RE Woods, KD Listrom, CD McKinnon, K Alali, A Bos, LS Iacobucci, ML Sramkoski, MR Jacobberger, JW Laughlin, MJ

Citation: S. Kadereit et al., Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes, BLOOD, 94(9), 1999, pp. 3101-3107